Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Computer-assisted insulin dosage adjustment.

A Schiffrin, M Mihic, B S Leibel

    Diabetes Care
    |November 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pronounced polarization-induced energy level shifts at boundaries of organic semiconductor nanostructures.

    Nature communications·2015
    Same author

    Collinear generation of ultrashort UV and XUV pulses.

    Optics express·2010
    Same author

    Banting-the man I knew.

    Canadian family physician Medecin de famille canadien·2010
    Same author

    Dimerization boosts one-dimensional mobility of conformationally adapted porphyrins on a hexagonal surface atomic lattice.

    Nano letters·2009
    Same author

    Technophobia, prescription checking and the future of diabetes management.

    Diabetologia·2009
    Same author

    Temperature dependence of conformation, chemical state, and metal-directed assembly of tetrapyridyl-porphyrin on Cu(111).

    The Journal of chemical physics·2008
    Same journal

    A Secular Increase in the Incidence of Islet Autoimmunity Among Colorado Children With Moderate-Risk HLA Genotypes.

    Diabetes care·2026
    Same journal

    Clinical and Biochemical Recovery From Immune Checkpoint Inhibitor-Induced Diabetes With Seroconversion of GAD Antibodies.

    Diabetes care·2026
    Same journal

    State Insulin Out-of-Pocket Cap Policies and Estimated Eligible Populations in the United States, 2019-2026.

    Diabetes care·2026
    Same journal

    Genetic Determinants of Macronutrient Intake Are Associated With Specific Food Intake in Youth: A Cohort Study Across Childhood and Adolescence.

    Diabetes care·2026
    Same journal

    A Novel Electronic Medical Record Search Method to Identify Patients With Ketosis-Prone Diabetes: Implications for Discovery of Atypical Diabetes.

    Diabetes care·2026
    Same journal

    Real-Time Continuous Glucose Monitoring Among People With Type 2 Diabetes and End-Stage Kidney Failure Undergoing Maintenance Hemodialysis: A Randomized Clinical Trial.

    Diabetes care·2026
    See all related articles

    A new microprocessor device significantly improved diabetes management by helping patients adjust insulin therapy. This technology led to lower blood glucose levels and reduced glycemic variability in insulin-dependent individuals.

    Area of Science:

    • Biomedical Engineering
    • Endocrinology
    • Diabetes Technology

    Background:

    • Diabetes management requires precise insulin therapy adjustments.
    • Capillary blood glucose (CBG) monitoring is crucial for self-adjustment.
    • Existing manual adjustment schemes can be complex for patients.

    Purpose of the Study:

    • To evaluate the efficacy of a novel microprocessor device for insulin therapy adjustment in diabetic individuals.
    • To assess the impact of the device on capillary blood glucose (CBG) levels and glycemic variability.
    • To determine the feasibility of using such a device in an outpatient setting.

    Main Methods:

    • A microprocessor device (BCMC) was used by seven type I diabetic individuals.
    • Patients entered CBG data and received insulin dosage recommendations.

    Related Experiment Videos

  • A control period of manual adjustment preceded the 8-week device usage period.

    • Main Results:

    • Significant reductions in mean CBG levels were observed across all measurement times (pre-breakfast, pre-lunch, pre-dinner, pre-bedtime).
    • Glycemic values decreased significantly, moving closer to the target of 110 mg/dl.
    • A significant reduction in the variability of glycemia before main meals was noted.

    Conclusions:

    • The microprocessor device effectively assists in adjusting insulin therapy for improved diabetes control.
    • The technology demonstrates potential for enhancing outpatient diabetes management.
    • Further research can explore wider adoption and long-term benefits of such devices.